ENTUK
Improve patient care & promote understanding of conditions of the ear, nose, throat, head & neck Provide information to the public & media Encourage & support research & provide continuing education for specialists Encourage recruitment into the specialty Promote high standards in specialist trainingRepresent the specialty at the Royal Colleges of Surgeons and to government bodies.
Objects
THE ADVANCEMENT FOR THE PUBLIC BENEFIT OF EDUCATION, TRAINING AND RESEARCH IN THE FIELDS OF OTORHINOLARYNGOLOGY - HEAD AND NECK SURGERY;THE RELIEF OF PATIENTS SUFFERING FROM DISEASES IN THE EAR, NOSE AND THROAT AND RELATED AREAS.
Financial health, per its FY2025 accounts
The accounts state that the Group remains in a strong and stable financial position with unrestricted reserves of £3.89 million and cash balances of £1.26 million. Although the Group recorded a net operating deficit of £24,328 before investment gains, the overall net surplus was £106,878 due to a revaluation gain on investments. The Trustees consider current reserve levels appropriate to manage financial risks and support ongoing commitments.
What the accounts disclose
“Reserves are set with reference to a defined period of core operating expenditure, expressed as approximately twelve months of cover.” — page 29
“The trading subsidiary, ENTUK Enterprises Ltd, delivers the annual calendar of events including the BACO conference.” — page 26
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Corporate structure
- Registered company of the charity Companies House 06452601
- Trading subsidiary: ENTUK ENTERPRISES LTD Companies House 15645555 · Financial health read from its filings
- Turnover: £269k
- Profit before tax: £15k
- Amounts owed to group undertakings and undertakings in which the company has a participating interest 7 202,997
Funders the charity credits
- Olympus
- Medtronic
- Ambu
- Mylan UK Healthcare
Company officers (Companies House)
- KANZARA, Todd Tafadzwa on trustee list
- PALERI, Vinidh, Professor on trustee list
- BARUAH, Paramita on trustee list
- TATLA, Taranjit Singh on trustee list
- MOORTHY, Ram Pragash on trustee list
- WEATHERILL, Nigel Peter, Professor on trustee list
- CARRIE, Sean on trustee list
- HANLY, Elaine not on trustee list
- LEGGET-JONES, Janet Marianne on trustee list
- COCKS, Helen on trustee list
- NIRMAL KUMAR, Balasubrahmanyam, Professor not on trustee list
- STRATFORD, Amanda Elspeth
Structured financials (annual return, FY ending 30/09/2025)
Register events
- Received assets from another charity (06/01/2023)
Trustees
- TARANJIT SINGH TATLAchair
- Elaine Hanley
- Helen Cocks
- Janet Marianne Legget-Jones
- PROFESSOR NIRMAL KUMAR
- Paramita Baruah
- Professor Nigel Peter Weatherill
- Professor Vinidh Paleri
- RAM P MOORTHY
- Sean Carrie
- Todd Kanzara
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £971k | £995k |
| 30/09/2024 | £939k | £860k |
| 30/09/2023 | £1.7m | £1.4m |
| 30/09/2022 | £729k | £705k |
| 30/09/2021 | £1.0m | £798k |
Common questions
Is ENTUK financially healthy?
Per its FY2025 accounts: The accounts state that the Group remains in a strong and stable financial position with unrestricted reserves of £3.89 million and cash balances of £1.26 million. Although the Group recorded a net operating deficit of £24,328 before investment gains, the overall net surplus was £106,878 due to a revaluation gain on investments. The Trustees consider current reserve levels appropriate to manage financial risks and support ongoing commitments. Its FY2025 accounts were audited by Edmund Carr LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE REED FOUNDATION | 1 | — |
| ROSETREES | 1 | £120k |
| THE ADRIAN SWIRE CHARITABLE TRUST | 1 | £100k |
| GLOBAL HEALTH PARTNERSHIPS | 1 | £63k |
| THE FRANCES AND AUGUSTUS NEWMAN FOUNDATION | 1 | £53k |
| DINWOODIE CHARITABLE COMPANY | 1 | £34k |
| THE GET A HEAD CHARITABLE TRUST | 1 | £30k |
| ROBERT LUFF FOUNDATION LIMITED | 1 | £25k |
Charities like this
- THE BRITISH ASSOCIATION OF HEAD AND NECK ONCOLOGISTS
- J.L.O. (1984) LIMITED
- BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS
- ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH
- THE BRITISH SOCIETY OF AUDIOLOGY
- Oracle Head and Neck Cancer UK Limited
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ENTUK | £971k | — | — | unclear | — | no doubt |
| THE BRITISH ASSOCIATION OF HEAD AND NECK ONCOLOGISTS | £240k | — | 0 | unclear | — | no doubt |
| J.L.O. (1984) LIMITED | £202k | Under £60,000 | 0 | unclear | — | no doubt |
| BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS | £207k | — | 0 | above | — | no doubt |
| ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH | £105k | — | 0 | below | — | noted |
| THE BRITISH SOCIETY OF AUDIOLOGY | £133k | — | 0 | unclear | — | no doubt |